New pill aims to slow Parkinson's in groundbreaking trial
Disease control
Not yet recruiting
This study is testing whether a new oral medication, GT-02287, can slow the progression of Parkinson's disease. It will involve about 111 people with early-stage Parkinson's, who will take either the drug or a placebo for 48 weeks. Researchers will measure changes in movement, da…
Phase: PHASE2 • Sponsor: Gain Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC